Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy
Source abstract
Abstract
Correction for ‘A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy’ by Zhengze Lu et al. , Nanoscale , 2018, 10 , 9957–9970, https://doi.org/10.1039/C8NR01184B.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China
Funding
National Natural Science Foundation of China
References
Reference metadata was not supplied for this record.